Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A joint physics and radiobiology DREAM team vision - Towards better response prediction models to advance radiotherapy.
Vens C, van Luijk P, Vogelius RI, El Naqa I, Humbert-Vidan L, von Neubeck C, Gomez-Roman N, Bahn E, Brualla L, Böhlen TT, Ecker S, Koch R, Handeland A, Pereira S, Possenti L, Rancati T, Todor D, Vanderstraeten B, Van Heerden M, Ullrich W, Jackson M, Alber M, Marignol L; ESTRO DREAM team. Vens C, et al. Among authors: van luijk p. Radiother Oncol. 2024 Jul;196:110277. doi: 10.1016/j.radonc.2024.110277. Epub 2024 Apr 25. Radiother Oncol. 2024. PMID: 38670264 Free article. Review.
External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy.
Beetz I, Schilstra C, van Luijk P, Christianen ME, Doornaert P, Bijl HP, Chouvalova O, van den Heuvel ER, Steenbakkers RJ, Langendijk JA. Beetz I, et al. Among authors: van luijk p, van den heuvel er. Radiother Oncol. 2012 Oct;105(1):94-100. doi: 10.1016/j.radonc.2011.11.006. Epub 2011 Dec 12. Radiother Oncol. 2012. PMID: 22169766
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I, Schilstra C, van der Schaaf A, van den Heuvel ER, Doornaert P, van Luijk P, Vissink A, van der Laan BF, Leemans CR, Bijl HP, Christianen ME, Steenbakkers RJ, Langendijk JA. Beetz I, et al. Among authors: van der schaaf a, van luijk p, van der laan bf, van den heuvel er. Radiother Oncol. 2012 Oct;105(1):101-6. doi: 10.1016/j.radonc.2012.03.004. Epub 2012 Apr 18. Radiother Oncol. 2012. PMID: 22516776 Free article.
69 results